Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)

This publication has 11 references indexed in Scilit:

• Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
  The Lancet Infectious Diseases, 2022
• Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
  The Lancet Infectious Diseases, 2022
• Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study
  Clinical Infectious Diseases, 2022
• Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
  Med, 2022
• Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
  The Lancet, 2022
• Clinical Characteristics of SARS-CoV-2 Omicron Infection in Children under One Year
  SSRN Electronic Journal, 2022
• Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
  The Lancet, 2022
• Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
  Cellular & Molecular Immunology, 2022
• Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
  The Lancet, 2021
• Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020
  Eurosurveillance, 2020